Clinical Trials Browser

Phase 3 × HER2-positive Carcinoma of Breast × Trastuzumab × Clear all

NCT02162667 2022-08-03

Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer

Phase 3 Completed

562 enrolled 15 charts

HER2-positive Carcinoma of Breast